THE EFFECT OF CHEMOTHERAPY HOLIDAY ON THE OVERALL SURVIVAL OF PATIENTS WITH ADVANCED COLORECTAL CANCER: A META-ANALYSIS OF RANDOMIZED TRIALS

被引:0
|
作者
Pereira, A. A. L. [1 ]
Rego, J. F. M. [2 ]
Hoff, P. M. [1 ]
Sasse, A. [3 ]
Riechelmann, R. P. [2 ]
机构
[1] Sirio Libanes Hosp, Ctr Oncol Andar 2, Sao Paulo, Brazil
[2] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
[3] UNICAMP Univ Estadual Campinas, Cevon Ctr Evidences Oncol, Campinas, SP, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:181 / 181
页数:1
相关论文
共 50 条
  • [21] Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trials
    Zhang, Tao
    Ding, Xin
    Wei, Dong
    Cheng, Peng
    Su, Xiaomei
    Liu, Huanyi
    Wang, Daoyuan
    Gao, Hui
    ANTI-CANCER DRUGS, 2010, 21 (03) : 326 - 332
  • [22] Safety of Bevacizumab in Patients with Advanced Cancer: A Meta-Analysis of Randomized Controlled Trials
    Geiger-Gritsch, Sabine
    Stollenwerk, Bjoern
    Miksad, Rebecca
    Guba, Beate
    Wild, Claudia
    Siebert, Uwe
    ONCOLOGIST, 2010, 15 (11): : 1179 - 1191
  • [23] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
    Yunfei Cao
    Aihua Tan
    Feng Gao
    Lidan Liu
    Cun Liao
    Zengnan Mo
    International Journal of Colorectal Disease, 2009, 24 : 677 - 685
  • [24] A meta-analysis of randomized controlled trials comparing chemotherapy plus bevacizumab with chemotherapy alone in metastatic colorectal cancer
    Cao, Yunfei
    Tan, Aihua
    Gao, Feng
    Liu, Lidan
    Liao, Cun
    Mo, Zengnan
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2009, 24 (06) : 677 - 685
  • [25] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [26] Progression-free survival (PFS) as a surrogate for overall survival (OS) in patients with advanced colorectal cancer: An analysis of 3159 patients randomized in 11 trials.
    Buyse, M
    Burzykowski, T
    Carroll, K
    Michiels, S
    Pignon, JP
    Piedbois, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 249S - 249S
  • [27] Efficacy and Safety of Bevacizumab and Chemotherapy in Combination with Atezolizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
    Jiang, Chenfei
    Chen, Dong
    Sun, Bin
    Wang, Rujia
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (09): : 4547 - 4554
  • [28] Meta-analyses of randomized controlled trials show suboptimal validity of surrogate outcomes for overall survival in advanced colorectal cancer
    Ciani, Oriana
    Buyse, Marc
    Garside, Ruth
    Peters, Jaime
    Saad, Everardo D.
    Stein, Ken
    Taylor, Rod S.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2015, 68 (07) : 833 - 842
  • [29] Adjuvant Chemotherapy for Advanced Gastric Cancer in Elderly and Non-elderly Patients: Meta-Analysis of Randomized Controlled Trials
    Chang, Seong-Hwan
    Kim, Soo-Nyung
    Choi, Hye Jung
    Park, Misuk
    Kim, Rock Bum
    Go, Se-Il
    Lee, Won Sup
    CANCER RESEARCH AND TREATMENT, 2017, 49 (01): : 263 - 273
  • [30] Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies
    Shuangjie Wu
    Jun Liu
    Xinhai Wang
    Mengjun Li
    Yu Gan
    Yifan Tang
    Cancer Causes & Control, 2014, 25 : 1489 - 1502